Velocity Medical Analysis invests in Indian tech, acquires TrierHealth

Share

DURHAM, N.C., Feb. 22, 2022 /PRNewswire/ — US-based Velocity Medical Analysis (“Velocity”), the world’s largest totally built-in scientific web site group, at this time publicizes its acquisition of TrierHealth, digital scientific trials platform whose R&D group operates out of Hyderabad, India, to develop patient-focused know-how. TrierHealth’s founder, Raghu Punnamraju, will develop into Velocity’s Chief Expertise Officer.

The funding in Indian scientific know-how experience in Hyderabad comes amid the scientific trials sector’s transfer in direction of decentralised trials. Velocity Medical Analysis operates 30 places throughout the US and can develop to different areas this yr, adopting a hybrid answer of each brick-and-mortar websites plus know-how components to facilitate higher affected person recruitment into scientific analysis globally, dashing up drug improvement.

Prior to now 12 months, Velocity has randomized 25,000 sufferers into section II and III research within the U.S. Velocity will now embark on an aggressive recruitment drive for scientific know-how expertise in Hyderabad, crucial to the corporate’s progress as a worldwide scientific trials participant.

Velocity, now with its acquired technical functionality, will develop patient-focused tech to extend affected person engagement amongst its database of 500,000 sufferers, growing the frequency of individuals collaborating in a number of research.

Dr G. Paul Evans, Chief Government and President of Velocity Medical Analysis, mentioned, “We’re constructing a worldwide neighborhood of sufferers who’re engaged, advocate for participation in scientific analysis, and actively participate in a number of research. We appeared to Hyderabad for its well-known status as a hub for know-how improvement inside Life Sciences. It has the certified workforce with the experience we’re on the lookout for that can permit us to scale the group in step with our formidable progress goals.

Read Also:  Tech Crash or Cut price Season? It’s an Open Query

“The experienceof the COVID pandemic and subsequent race to discover a vaccine demonstrated there’s a want for extra user-friendly know-how purposes that permits extra folks to take part in scientific analysis. Velocity, along with the experience acquired from TrierHealth, is setting a brand new normal of integration for the analysis web site trade to raised recruit and retain sufferers into scientific analysis.”

The acquisition of TrierHealth means Velocity can develop purposes that harnesses the facility of AI and information science to enhance scientific analysis. The acquisition comes 18 months after collaborating with TrierHealth to construct a patient-focused platform to assist decentralized visits. The R&D group, primarily based in Hyderabad, will now develop and concentrate on affected person recruitment and retention purposes.

Raghu Punnamraju, Velocity’s new Chief Expertise Officer, mentioned: “Expertise touches each a part of our lives and scientific analysis is not any totally different. As we more and more transfer in direction of decentralised scientific analysis, the tech wants to enhance. We’re setting the usual for user-oriented know-how that’s as simple to make use of as Amazon.

“Authorities in Hyderabad has taken a number of measures to determine a sustained ecosystem for all times sciences, together with academia, infrastructure, and employment. Consequently, Hyderabad’s tech trade has all the time stayed on high the most recent improvements. The ecosystem has expertise in abundance and makes it simple for organizations to determine their workforce and so I’m delighted to be actively constructing out the core capabilities of our group in Hyderabad.”

Raghu Punnamraju brings intensive software program and trade expertise, together with eight years with Parexel Informatics, and turns at Intermountain Healthcare in Utah, and GE Healthcare. Velocity will embark on a recruitment drive in Hyderabad for developer experience because it expands its capabilities.

Read Also:  10 issues in tech it is advisable to know at this time

Velocity was the one US firm to recruit sufferers to all Operation Warp Pace COVID vaccine trials, plus Pfizer, randomizing 10% of all volunteers within the US to COVID research.

Notes to editors:

?  A full record of Velocity’s websites may be discovered on its web site.

About Velocity Medical Analysis

Velocity Medical Analysis, headquartered in Durham, NC, is the main built-in web site group for scientific trials, providing devoted web site capabilities to assist biopharmaceutical and contract analysis group clients discover the precise sufferers for his or her research. Velocity helps world drug improvement in primarily conducting section II and section III scientific trials. The corporate has 30 U.S. places throughout 14 states.

We place the care of the affected person on the coronary heart of all the pieces we do. With over 35 years of expertise working websites and greater than 7,000 research accomplished, Velocity has refined its affected person recruitment methods whereas sustaining a concentrate on delivering well timed and dependable information high quality. For extra info go to our web site at https://velocityclinical.com.

About TrierHealth

TrierHealth, headquartered in San Jose, CA was a know-how startup integrated with a single mission – Enhance affected person journey with edge applied sciences. TrierHealth, with its R&D group primarily based out of Hyderabad India, has developed a platform that brings AI, information science and cell applied sciences collectively to interact the sufferers all through their scientific analysis journey. For extra info, please go to https://www.trierhealth.com/.

Photograph – https://mma.prnewswire.com/media/1750952/Velocity_Raghu_Punnamraju.jpg
Brand – https://mma.prnewswire.com/media/1332237/1045132_Logo.jpg

 

 

Velocity Clinical Research (PRNewsfoto/Velocity Clinical Research)

[ Back To TMCnet.com’s Homepage ]

Read Also:  Lidl is selling a bargain kitchen gadget that shoppers say is the best £30 they’ve ever spent